Acetylsalicylic acid Completed Phase 4 Trials for Cerebral Infarctions Prevention

IndicationsStatusPurposePhase
CompletedPrevention4
clinicaltrials.gov IdentifierTitleDrugs
NCT00234065Post-marketing Study of Cilostazol (Cilostazol Stroke Prevention Study 2)